Trial Information

Summary: Want the freedom from sudden urinary urge?

This is a placebo controlled randomized,dose ranging, double-blind study vs. placebo as a study comparator, to evaluate efficacy and safety of SSR240600C for women with OAB including Urge Urinary Incontinence.The study will last approximately 16 weeks with 8 visits. You will be compensated for your time and travel upon completion of study.

Patient Inclusion Criteria:

• Female age 18-70
• Diagnosed with OAB with symptoms of UUI
• 5 UUI episodes per week
• Urgency at least 1 episode per 24 hours
• Urinary frequency at least 8 maturations per 24 hours

Patient Exclusion Criteria:

• Stress incontinence or mixed incontinence where stress incontinence is the predominant component based on prior history
• Current UTI or frequent UTIs (i.e., greater than or equal to 5 UTIs per year)
• Pain during voiding or bladder pain without voiding
• History of interstitial cystitis or bladder related pain syndrome
• Chronic GI condition associated with frequent, recurrent or intermittent diarrhea(eg, D-IBS, IBD, Celiac sprue, etc)
• Any OAB or UUI treatment within the last 30 days prior to entering screening including herbal or over-the-counter formulations
• Study participation within the last 3 months
• < than 88lbs
• Any history of allergy to Detrol
• Pregnant or breast feeding, if of childbearing potential, must be on two forms of reliable contraception

If you would like to learn more about participating in this study, please send an e-mail message using the form below.